vs

Side-by-side financial comparison of ARVINAS, INC. (ARVN) and Ponce Financial Group, Inc. (PDLB). Click either name above to swap in a different company.

ARVINAS, INC. is the larger business by last-quarter revenue ($41.9M vs $31.4M, roughly 1.3× Ponce Financial Group, Inc.). Ponce Financial Group, Inc. runs the higher net margin — 36.3% vs -83.8%, a 120.1% gap on every dollar of revenue. On growth, Ponce Financial Group, Inc. posted the faster year-over-year revenue change (37.6% vs -59.1%). Ponce Financial Group, Inc. produced more free cash flow last quarter ($54.6M vs $-59.2M). Over the past eight quarters, Ponce Financial Group, Inc.'s revenue compounded faster (23.7% CAGR vs 10.0%).

Arvinas, Inc. is a clinical-stage biotechnology company focused on developing targeted protein degradation therapies, including PROTAC molecules, to treat cancer and rare diseases. It operates primarily in the U.S. and global biopharma markets, advancing multiple pipeline candidates through clinical trials to address unmet medical needs.

Ponce Financial Group, Inc. is a U.S.-based financial holding company operating Ponce Bank as its core subsidiary. It serves multicultural, immigrant and low-to-moderate income communities in the New York metro area, offering retail and commercial banking products including deposits, mortgages, small business financing and personal credit.

ARVN vs PDLB — Head-to-Head

Bigger by revenue
ARVN
ARVN
1.3× larger
ARVN
$41.9M
$31.4M
PDLB
Growing faster (revenue YoY)
PDLB
PDLB
+96.7% gap
PDLB
37.6%
-59.1%
ARVN
Higher net margin
PDLB
PDLB
120.1% more per $
PDLB
36.3%
-83.8%
ARVN
More free cash flow
PDLB
PDLB
$113.8M more FCF
PDLB
$54.6M
$-59.2M
ARVN
Faster 2-yr revenue CAGR
PDLB
PDLB
Annualised
PDLB
23.7%
10.0%
ARVN

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
ARVN
ARVN
PDLB
PDLB
Revenue
$41.9M
$31.4M
Net Profit
$-35.1M
$10.1M
Gross Margin
Operating Margin
-104.5%
43.6%
Net Margin
-83.8%
36.3%
Revenue YoY
-59.1%
37.6%
Net Profit YoY
28.7%
245.6%
EPS (diluted)
$-0.48
$0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARVN
ARVN
PDLB
PDLB
Q4 25
$31.4M
Q3 25
$41.9M
$26.7M
Q2 25
$26.5M
Q1 25
$188.8M
$24.6M
Q4 24
$59.2M
$22.8M
Q3 24
$102.4M
$20.2M
Q2 24
$76.5M
$20.2M
Q1 24
$25.3M
$20.5M
Net Profit
ARVN
ARVN
PDLB
PDLB
Q4 25
$10.1M
Q3 25
$-35.1M
$6.5M
Q2 25
$6.1M
Q1 25
$82.9M
$6.0M
Q4 24
$-45.1M
$2.9M
Q3 24
$-49.2M
$2.4M
Q2 24
$-35.2M
$3.2M
Q1 24
$-69.4M
$2.4M
Operating Margin
ARVN
ARVN
PDLB
PDLB
Q4 25
43.6%
Q3 25
-104.5%
32.8%
Q2 25
30.2%
Q1 25
37.8%
32.5%
Q4 24
-98.1%
19.6%
Q3 24
-58.9%
15.2%
Q2 24
-63.4%
21.8%
Q1 24
-329.2%
18.3%
Net Margin
ARVN
ARVN
PDLB
PDLB
Q4 25
36.3%
Q3 25
-83.8%
24.3%
Q2 25
23.0%
Q1 25
43.9%
24.2%
Q4 24
-76.2%
14.1%
Q3 24
-48.0%
12.1%
Q2 24
-46.0%
15.8%
Q1 24
-274.3%
11.8%
EPS (diluted)
ARVN
ARVN
PDLB
PDLB
Q4 25
$0.43
Q3 25
$-0.48
$0.27
Q2 25
$0.25
Q1 25
$1.14
$0.25
Q4 24
$-0.63
$0.11
Q3 24
$-0.68
$0.10
Q2 24
$-0.49
$0.14
Q1 24
$-0.97
$0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARVN
ARVN
PDLB
PDLB
Cash + ST InvestmentsLiquidity on hand
$787.6M
$126.2M
Total DebtLower is stronger
$600.0K
$596.1M
Stockholders' EquityBook value
$564.4M
$541.5M
Total Assets
$844.3M
$3.2B
Debt / EquityLower = less leverage
0.00×
1.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARVN
ARVN
PDLB
PDLB
Q4 25
$126.2M
Q3 25
$787.6M
$146.6M
Q2 25
$126.6M
Q1 25
$954.3M
$129.9M
Q4 24
$1.0B
$139.8M
Q3 24
$1.1B
$155.8M
Q2 24
$1.2B
$103.2M
Q1 24
$1.2B
$134.7M
Total Debt
ARVN
ARVN
PDLB
PDLB
Q4 25
$596.1M
Q3 25
$600.0K
$521.1M
Q2 25
$536.1M
Q1 25
$700.0K
$521.1M
Q4 24
$800.0K
$596.1M
Q3 24
$800.0K
$580.4M
Q2 24
$900.0K
$680.4M
Q1 24
$900.0K
$680.4M
Stockholders' Equity
ARVN
ARVN
PDLB
PDLB
Q4 25
$541.5M
Q3 25
$564.4M
$529.8M
Q2 25
$521.1M
Q1 25
$660.1M
$513.9M
Q4 24
$561.7M
$505.5M
Q3 24
$586.0M
$504.6M
Q2 24
$600.2M
$497.7M
Q1 24
$609.7M
$493.7M
Total Assets
ARVN
ARVN
PDLB
PDLB
Q4 25
$3.2B
Q3 25
$844.3M
$3.2B
Q2 25
$3.2B
Q1 25
$1.0B
$3.1B
Q4 24
$1.1B
$3.0B
Q3 24
$1.2B
$3.0B
Q2 24
$1.3B
$2.8B
Q1 24
$1.2B
$2.8B
Debt / Equity
ARVN
ARVN
PDLB
PDLB
Q4 25
1.10×
Q3 25
0.00×
0.98×
Q2 25
1.03×
Q1 25
0.00×
1.01×
Q4 24
0.00×
1.18×
Q3 24
0.00×
1.15×
Q2 24
0.00×
1.37×
Q1 24
0.00×
1.38×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARVN
ARVN
PDLB
PDLB
Operating Cash FlowLast quarter
$-59.1M
$55.6M
Free Cash FlowOCF − Capex
$-59.2M
$54.6M
FCF MarginFCF / Revenue
-141.3%
173.9%
Capex IntensityCapex / Revenue
0.2%
3.1%
Cash ConversionOCF / Net Profit
5.48×
TTM Free Cash FlowTrailing 4 quarters
$-361.6M
$74.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARVN
ARVN
PDLB
PDLB
Q4 25
$55.6M
Q3 25
$-59.1M
$1.4M
Q2 25
$6.2M
Q1 25
$-88.9M
$13.1M
Q4 24
$-84.1M
$7.2M
Q3 24
$-128.0M
$-14.6M
Q2 24
$50.3M
$-2.6M
Q1 24
$-97.5M
$1.5M
Free Cash Flow
ARVN
ARVN
PDLB
PDLB
Q4 25
$54.6M
Q3 25
$-59.2M
$786.0K
Q2 25
$5.9M
Q1 25
$-89.3M
$12.9M
Q4 24
$-84.4M
$4.5M
Q3 24
$-128.7M
$-15.0M
Q2 24
$49.6M
$-2.6M
Q1 24
$-97.6M
$-315.0K
FCF Margin
ARVN
ARVN
PDLB
PDLB
Q4 25
173.9%
Q3 25
-141.3%
2.9%
Q2 25
22.4%
Q1 25
-47.3%
52.6%
Q4 24
-142.6%
19.7%
Q3 24
-125.7%
-74.1%
Q2 24
64.8%
-13.0%
Q1 24
-385.8%
-1.5%
Capex Intensity
ARVN
ARVN
PDLB
PDLB
Q4 25
3.1%
Q3 25
0.2%
2.3%
Q2 25
1.0%
Q1 25
0.2%
0.6%
Q4 24
0.5%
11.9%
Q3 24
0.7%
2.0%
Q2 24
0.9%
0.3%
Q1 24
0.4%
8.7%
Cash Conversion
ARVN
ARVN
PDLB
PDLB
Q4 25
5.48×
Q3 25
0.21×
Q2 25
1.01×
Q1 25
-1.07×
2.20×
Q4 24
2.46×
Q3 24
-5.99×
Q2 24
-0.80×
Q1 24
0.61×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons